Inhibrx Biosciences, Inc. (INBX) vs Keros Therapeutics, Inc. (KROS)
Detailed comparison between Inhibrx Biosciences, Inc., Keros Therapeutics, Inc..Total Return (%)
Inhibrx Biosciences, Inc. (INBX)Keros Therapeutics, Inc. (KROS)
Which stock do you think will perform better?
Inhibrx Biosciences, Inc.
INBX
Keros Therapeutics, Inc.
KROS
| Metric | Inhibrx Biosciences, Inc. (INBX) | Keros Therapeutics, Inc. (KROS) |
|---|---|---|
| Current Price | $33.58 | $15.79 |
| Change | 1.26 (3.92%) | -0.16 (-1.03%) |
| Market Cap | $0.49B | $0.65B |
| Trailing P/E | 0.00 | 49.33 |
| Forward P/E | -3.04 | -2.77 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $33.98 | $72.37 |
| 52-Week Low | $10.80 | $9.12 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-16.38 | $0.32 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| INBX | 21.56% | 147.24% | 117.31% | 168.46% | 168.46% | 168.46% |
| KROS | 0.41% | 38.46% | -73.60% | -58.03% | -21.39% | -21.39% |